|
Indications and Dosage
Topical/Cutaneous
Pain and inflammation Adult: For relief of rheumatic pain, pain of non-serious arthritic conditions, and soft tissue injuries: As 3% gel or 3.17% foam: Gently rub approx 1 inch (2.5 cm) of gel or 1.5 inches (4 cm) of foam over affected area(s) 2-4 times daily. Max: 25 g daily (irrespective of the size or number of affected areas). Review therapy after 14 days.
|
|
Contraindications
Hypersensitivity (including patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by aspirin or other NSAIDs). Pregnancy and lactation.
|
|
Adverse Reactions
Significant: Asthma, renal disease, anaphylaxis (application of large amount).
Nervous: Paraesthesia. GI: GI disturbance, dyspepsia. Resp: Bronchospasm, dyspnoea, wheezing. Dermatologic: Pruritus, rash, dermatitis, angioedema, purpura, epidermal necrolysis, erythema multiforme, photosensitivity, application site reactions. |
|
Patient Counseling Information
Avoid application to broken skin, contact w/ eyes or mucous membranes, use of occlusive dressings, and excessive exposure of treated area to sunlight.
|
|
Drug Interactions
Increased incidence of adverse reactions w/ aspirin or other NSAIDs.
|
|
Action
Description:
Mechanism of Action: Felbinac is the active metabolite of fenbufen. It is used topically for local treatment of pain and inflammation of the musculoskeletal system. Pharmacokinetics: Absorption: Topical application results in low circulating levels of felbinac. Distribution: Distributed preferentially to site of inflammation. |
|
Storage
Store below 25°C.
|
|
ATC Classification
M02AA08 - felbinac ; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains.
|
|
References
Buckingham R (ed). Felbinac. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 21/02/2017. Joint Formulary Committee. Felbinac. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 21/02/2017.
|
Sign Out
